Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid

New England Journal of Medicine

Volumn 341, Issue 16, 1999, Pages 1165-1173

  Matthay, Katherine K ^a   Villablanca, Judith G ^b   Seeger, Robert C ^b   Stram, Daniel O ^a   Harris, Richard E ^b   Ramsay, Norma K ^b   Swift, Patrick ^b   Shimada, Hiroyuki ^b   Black, C Thomas ^b   Brodeur, Garrett M ^b   Gerbing, Robert B ^a   Reynolds, C Patrick ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; ISOTRETINOIN; MELPHALAN; MYELOABLATIVE AGENT;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; INFANT; ISOTRETINOIN; LIFE TABLES; NEUROBLASTOMA; PROSPECTIVE STUDIES; RISK; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 0033554684     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199910143411601     Document Type: Article

References (40)

1. Matthay KK. Neuroblastoma: biology and therapy. Oncology (Huntingt) 1997;11:1857-66, 1869-72, 1875.
2. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
3. Shimada H, Stram DO, Chatten J, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995;87:1470-6.
4. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997;19:93-101.
5. Cheung NV, Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 1991;9:1050-8.
6. Dini G, Philip T, Hartmann O, et al. Bone marrow transplantation for neuroblastoma: a review of 509 cases. Bone Marrow Transplant 1989;4: Suppl 4:42-6.
7. Dini G, Lanino E, Garaventa A, et al. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases. J Clin Oncol 1991;9:962-9.
8. Philip T, Zucker JM, Bernard JL, et al. Improved survival at 2 and 5 years in the LMCEI unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 1991;9:1037-44.
9. Kushner BH, O'Reilly RJ, Mandell LR, Gulati SC, LaQuaglia M, Cheung NK. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 1991;9:274-9.
10. Seeger RC, Reynolds CP. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 1991;38:393-424.
11. Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study. J Clin Oncol 1993;11:2226-33.
12. Ohnuma N, Takahashi H, Kaneko M, et al. Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan. Med Pediatr Oncol 1995;24:181-7.
13. Garaventa A, Rondelli R, Lanino E, et al. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma: report from the Italian Bone Marrow Transplant Registry. Bone Marrow Transplant 1996;18:125-30.
14. Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996;14:2417-26.
15. Ladenstein R, Philip T, Lasset C, et al. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol 1998; 16:953-65.
16. Melino G, Thiele CJ, Knight RA, Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol 1997;31:65-83.
17. Reynolds CP, Schindler PF, Jones DM, Gentile JL, Proffitt RT, Einhorn PA. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines. Prog Clin Biol Res 1994;385:237-44.
18. Abemayor E. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells. Laryngoscope 1992;102:1133-49.
19. Reynolds CP, Kane DJ, Einhorn PA, et al. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 1991;366:203-11.
20. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982;68:589-96.
21. Villablanca JG, Khan AA, Avramis VI, et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995;13:894-901.
22. Hann HW, Evans AE, Siegel SE, et al. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res 1985;45:2843-8.
23. Chatten J, Shimada H, Sather HN, Wong KY, Siegel SE, Hammond GD. Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group. Hum Pathol 1988;19:1187-98.
24. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
25. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
26. Seeger RC, Wada R, Brodeur GM, et al. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 1988;271:41-9.
27. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6:1874-81.
28. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
29. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-26.
30. Reynolds CP, Seeger RC, Vo DD, Black AT, Wells J, Ugelstad J. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 1986;46:5882-6.
31. Matthay KK, Seeger RC, Reynolds CP, et al. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. J Clin Oncol 1994;12:2382-9.
32. Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Controlled Clin Trials 1984;5:348-61.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
34. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976;34:585-612.
35. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991;75:405-9.
36. Oursler DP, Holley KE, Wagoner RD. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am J Nephrol 1993;13:167-70.
37. Tarbell NJ, Guinan EC, Chin L, Mauch P, Weinstein HJ. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 1990;18:Suppl 1:139-42.
38. Shuster JJ. The role of autologous bone marrow transplantation in advanced neuroblastoma. J Clin Oncol 1996;14:2413-4.
39. Pinkerton CR. ENSG 1-randomised study of high-dose melphalan in neuroblastoma. Bone Marrow Transplant 1991;7:Suppl 3:112-3.
40. Daubenton JD, Fisher RM, Karabus CD, Mann MD. The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 1987;59:1586-9.